# LYNKUET

NDC: 50419-475
Generic name: elinzanetant
Labeler / Manufacturer: Bayer HealthCare Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20251024

FDA application: NDA219469

## Active ingredients

- ELINZANETANT: 60 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50419-475"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50419-475
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f42884ff-7dff-419c-8a0c-affe2ed73818